HEART FAILURE: Edited by Haissam HaddadRight ventricular failure managementBakar, Shahrukh N.a; Jia, Sangyangb; Smith, Stuart J.cAuthor Information aDivision of Interventional Cardiology, Department of Medicine bSchulich School of Medicine & Dentistry cDivision of Cardiology, Department of Medicine, Western University, London, Ontario, Canada Correspondence to Stuart J. Smith, MD, FRCPC, University Hospital, London Health Sciences Centre, 339 Windermere Road, London, ON N6A 5A5, Canada. Tel: +1 (519) 663 3428; e-mail: firstname.lastname@example.org Current Opinion in Cardiology: March 2019 - Volume 34 - Issue 2 - p 213-217 doi: 10.1097/HCO.0000000000000595 Buy Metrics Abstract Purpose of review Review recent advances in the diagnosis and management of right ventricular (RV) failure. Recent findings Temporary and durable device-based management of RV failure has emerging applications. Summary Research advances and clinical management in RV failure have been limited by a lack of consensus on a universal definition. Echocardiographic and cardiac MRI-based predictors of RV failure are imperfect. Combinations of hemodynamic and imaging variables may have better predictive value. Loading conditions and ventriculo-arterial coupling play important roles in RV function. The current treatment approach to RV failure includes a combination of inotropy and vasodilatation but lacks conclusive evidence. Emerging biochemical and molecular targets hold promise but have yet to be proven in human studies. Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.